People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Other Technology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Prevedere, Inc. | — | Other Technology | Series B | $44.7M | $300.4M | 2015 |
| ZebiAI Therapeutics, Inc. | — | Pharma | Series A | $10.0M | $309.7M | 2019 |
Richard C Wagner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard C Wagner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Promod Haque | 1 | 13 |
| Krish Panu | 1 | 6 |
| Peter Thomas | 1 | 3 |
| Promod C. Haque | 1 | 2 |
| Richard Wagner | 1 | 2 |
| Ken Coleman | 1 | 2 |
| Daniel Fishback | 1 | 2 |
| Philip C. Austin | 1 | 1 |
| Don Fowler | 1 | 1 |
| Ken C Coleman | 1 | 1 |
| Peter C Thomas | 1 | 1 |
| Don C Fowler | 1 | 1 |
| Daniel C Fishback | 1 | 1 |
| Brant C. Binder | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.